Search Results - "Goetz, C.G."

O.030 Scales to evaluate psychosis in Parkinson's disease by Goetz, C.G

Get full text

Continuous in-home monitoring of essential tremor by Pulliam, C.L, Eichenseer, S.R, Goetz, C.G, Waln, O, Hunter, C.B, Jankovic, J, Vaillancourt, D.E, Giuffrida, J.P, Heldman, D.A

“…Abstract Background Essential tremor (ET) is typically measured in the clinic with subjective tremor rating scales which require the presence of a clinician…”
Get full text

Charcot: Past and present by Goetz, C.G.

“…Jean-Martin Charcot (1825–1893) was the preeminent neurologist of the nineteenth century. Several of his major contributions remain fully relevant to…”
Get full text

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy by Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D.J., Rothwell, J.C., Hallett, M., DeLong, M.R., Marras, C., Tanner, C.M., Ross, G.W., Langston, J.W., Klein, C., Bonifati, V., Jankovic, J., Lozano, A.M., Deuschl, G., Bergman, H., Tolosa, E., Rodriguez‐Violante, M., Fahn, S., Postuma, R.B., Berg, D., Marek, K., Standaert, D.G., Surmeier, D.J., Olanow, C.W., Kordower, J.H., Calabresi, P., Schapira, A.H.V., Stoessl, A.J.

“…ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he…”
Get full text

1.167 PRODEST – Depressive symptoms in Parkinson's disease: Pattern across scales by Barone, P, Goetz, C.G, Houben, J.J, Köster, J, Leentjens, A.F.G, Pöwe, W, Rascol, O, Reichmann, H, Schapira, A.H, Tolosa, E

Get full text

Charcot: Past and present by Goetz, C.G.

Get full text

Charcot, hysteria, and simulated disorders by Goetz, C G

“…Jean-Martin Charcot (1825-1893) was the 19th-century's premier international neurologist. One of his areas of focused interest was the neurologic disorder,…”
Get more information

FMR1 CGG repeat length predicts motor dysfunction in premutation carriers by LEEHEY, M. A, BERRY-KRAVIS, E, GANE, L, JACQUEMONT, S, TASSONE, F, GRIGSBY, J, HAGERMAN, R. J, HAGERMAN, P. J, GOETZ, C. G, ZHANG, L, HALL, D. A, LI, L, RICE, C. D, LARA, R, COGSWELL, J, REYNOLDS, A

“…Fragile X-associated tremor/ataxia syndrome (FXTAS) is a recently described, underrecognized neurodegenerative disorder of aging fragile X mental retardation 1…”
Get full text

III.1 Differential diagnosis in psychosis in Parkinson's Disease patients by Goetz, C.G.

Get full text

Clinimetric testing of the comprehensive cervical dystonia rating scale by Comella, Cynthia L., Perlmutter, Joel S., Jinnah, Hyder A., Waliczek, Tracy A., Rosen, Ami R., Galpern, Wendy R., Adler, Charles A., Barbano, Richard L., Factor, Stewart A., Goetz, Christopher G., Jankovic, Joseph, Reich, Stephen G., Rodriguez, Ramon L., Severt, William L., Zurowski, Mateusz, Fox, Susan H., Stebbins, Glenn T.

“…ABSTRACT Introduction The aim of this study was to test the clinimetric properties of the Comprehensive Cervical Dystonia Rating Scale. This is a modular scale…”
Get full text

Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : une nouvelle échelle pour l’évaluation de la maladie de Parkinson by Goetz, C.G.

Get full text

V.7 fMRI studies of psychosis in Parkinson's Disease by Goetz, C.G., Stebbins, G.T.

Get full text

Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients by GOETZ, C. G, BLASUCCI, L. M, LEURGANS, S, PAPPERT, E. J

“…To compare olanzapine and clozapine for safety and efficacy measures of psychosis and motor function in patients with PD and chronic hallucinations…”
Get full text

Decreased color discrimination and contrast sensitivity in Parkinson’s disease by Pieri, V., Diederich, N.J., Raman, R., Goetz, C.G.

“…Patients with Parkinson’s disease (PD) often complain of blurred vision or even of distinctive visual disturbances like hallucinations and illusions. Recent…”
Get full text

Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease by KOMPOLITI, K, WANG, Q. E, GOETZ, C. G, LEURGANS, S, RAMAN, R

“…To determine the effect of central dopaminergic stimulation with apomorphine on speech in PD. Most patients with PD have a speech disorder. Of those, 89% have…”
Get full text

Menstrual-related changes in motoric function in women with Parkinson's disease by KOMPOLITI, K, CORNELLA, C. L, JAGLIN, J. A, LEURGANS, S, RAMAN, R, GOETZ, C. G

“…Questionnaire studies have found that parkinsonism worsens in women during the premenstrual period, when estrogen and progesterone levels are presumably at…”
Get full text

PII: S0022-510X(02)00204-6 by Pieri, V, Diederich, N.J, Raman, R, Goetz, C.G

Get full text

Animal model of posthypoxic myoclonus : Effects of serotonergic antagonists by PAPPERT, E. J, GOETZ, C. G, VU, T. Q, LING, Z. D, LEURGANS, S, RAMAN, R, CARVEY, P. M

“…To study specific serotonin (5-hydroxytryptamine [5-HT]) receptor subtype antagonists in an animal model of posthypoxic myoclonus. Although serotonergic system…”
Get full text

Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures by Carvey, P M, Ptak, L R, Nath, S T, Sierens, D K, Mufson, E J, Goetz, C G, Klawans, H L

“…The caudate, putamen, and cerebellum from five patients with Parkinson's disease (PD) and five normal, aged controls were studied to determine if cell-free…”
Get more information

The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease by CARVEY, P. M, MCRAE, A, LANG, DR, FORNO, DR, LANGSTON, DR, LINT, T. F, PTAK, L. R, LO, E. S, GOETZ, C. G, KLAWANS, H. L, SANCHEZ-RAMOS, DR, ELLENBERG, DR, KOPIN, DR

“…The cerebral spinal fluid (CSF) of patients with Parkinson's disease (PD) contains an antibody that immunocytochemically reacts with dopamine (DA) neurons in…”
Get full text